Coronary artery disease is the most frequent cause of death in the elderly. The gold standard therapy for acute coronary syndrome (ACS) is early mechanical myocardial revascularization with either percutaneous intervention with stents (PCIS) or coronary artery bypass grafting (CABG). Although studies suggest that elderly patients with ACS may benefit from myocardial revascularization, these reports lack the power to determine optimum invasive myocardial strategy with respect to age, gender, race, comorbidities and geography. Our long range goal is to identify an efficacious invasive treatment strategy for ACS in the elderly. The central hypothesis of the proposed research is that surgical myocardial revascularization improves survival rates in ACS patients aged 65 and older with fewer reinterventions and decreased resource utilization than the more frequently prescribed strategy of PCIS. The principal objectives of this project are to use national Medicare hospital and physician claims from the Centers for Medicare & Medicaid Services to address four specific aims; 1) Identify the factors associated with diffusion of mechanical myocardial revascularization over the study period (2002-2006) in Medicare patients presenting with ACS; 2) Determine the influence of age, comorbidity presence, race, gender, and geographic location on the selection of mechanical revascularization strategy (PCIS or CABG); 3) Compare clinical outcomes and hospital/physician resource utilization with respect to the initial mechanism of mechanical revascularization treatment; 4) Determine if age, comorbidity presence, race and/or gender are associated with disparate outcomes within the selected treatment modality in Medicare ACS patients. We will use propensity score methods to control for mechanism of revascularization to reduce bias from selection. Key outcome measures include rates of rehospitalization, reyascularization, nursing home use, morbidity, new onset delirium, mortality, and Medicare hospital/physician expenditures over a four year follow-up period. A Markov model will be used to portray the relative effects of the two procedures. These results will guide future study design for treatment of ACS in the elderly. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
1R01AG025801-01A1
Application #
7099797
Study Section
Aging Systems and Geriatrics Study Section (ASG)
Program Officer
Nayfield, Susan G
Project Start
2007-09-15
Project End
2010-06-30
Budget Start
2007-09-15
Budget End
2008-06-30
Support Year
1
Fiscal Year
2007
Total Cost
$297,526
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Administration
Type
Schools of Public Health
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
D'Arcy, Laura P; Stearns, Sally C; Domino, Marisa E et al. (2013) Is geriatric care associated with less emergency department use? J Am Geriatr Soc 61:4-11
Federspiel, Jerome J; Stearns, Sally C; D'Arcy, Laura P et al. (2013) Resource use trajectories for aged medicare beneficiaries with complex coronary conditions. Health Serv Res 48:753-72
Federspiel, Jerome J; Stearns, Sally C; Reiter, Kristin L et al. (2013) Disappearing and reappearing differences in drug-eluting stent use by race. J Eval Clin Pract 19:256-62
Federspiel, Jerome J; Stearns, Sally C; Sheridan, Brett C et al. (2012) Evaluating the effectiveness of a rapidly adopted cardiovascular technology with administrative data: the case of drug-eluting stents for acute coronary syndromes. Am Heart J 164:207-14
Federspiel, Jerome J; Stearns, Sally C; Peppercorn, Amanda F et al. (2012) Increasing US rates of endocarditis with Staphylococcus aureus: 1999-2008. Arch Intern Med 172:363-5
Federspiel, Jerome J; Mudrick, Daniel W; Shah, Bimal R et al. (2012) Patterns and predictors of stress testing modality after percutaneous coronary stenting: data from the NCDR(®). JACC Cardiovasc Imaging 5:969-80
Rossi, Joseph S; Federspiel, Jerome J; Crespin, Daniel J et al. (2012) Stress imaging use and repeat revascularization among medicare patients with high-risk coronary artery disease. Am J Cardiol 110:1270-4
Crespin, Daniel J; Federspiel, Jerome J; Biddle, Andrea K et al. (2011) Ticagrelor versus genotype-driven antiplatelet therapy for secondary prevention after acute coronary syndrome: a cost-effectiveness analysis. Value Health 14:483-91
Federspiel, Jerome J; Stearns, Sally C; van Domburg, Ron T et al. (2011) Risk-benefit trade-offs in revascularisation choices. EuroIntervention 6:936-41
Sheridan, Brett C; Stearns, Sally C; Rossi, Joseph S et al. (2010) Three-year outcomes of multivessel revascularization in very elderly acute coronary syndrome patients. Ann Thorac Surg 89:1889-94; discussion 1894-5

Showing the most recent 10 out of 12 publications